Literature DB >> 18080332

2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18080332     DOI: 10.1002/ccd.21475

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


× No keyword cloud information.
  5 in total

1.  No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.

Authors:  Nadja Kuzniatsova; Balu Balakrishnan; Gregory Y H Lip; Andrew D Blann
Journal:  Int J Angiol       Date:  2012-12

2.  Periostin gene polymorphisms, protein levels and risk of incident coronary artery disease.

Authors:  Fangfang Wang; Cuan Yang; Ying Song; Ye Jiang; Zhijian Ding
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

3.  Imaging coronary and extracoronary atherosclerosis: feasibility and impact of whole-body computed tomography angiography.

Authors:  Alessandro Napoli; Carlo Catalano; Marco Francone; Vincenzo Sciacca; Iacopo Carbone; Cesare Greco; Michele Anzidei; Francesca Antonella Calabrese; Beatrice Cavallo Marincola; Miles A Kirchin; Annarita Vestri; Marcello Arca; Luigi Iuliano; Roberto Passariello
Journal:  Eur Radiol       Date:  2009-03-11       Impact factor: 5.315

4.  Clopidogrel resistance is associated with long-term thrombotic events in patients implanted with drug-eluting stents.

Authors:  Lin Wang; Xiaobei Wang; Fenghua Chen
Journal:  Drugs R D       Date:  2010

5.  Cytochrome P450 2C19 Polymorphism in Iranian Patients with Coronary Artery Disease.

Authors:  Arash Akhlaghi; Shahin Shirani; Naghmeh Ziaie; Omid Pirhaji; Majid Yaran; Golnoosh Shahverdi; Nizal Sarrafzadegan; Alireza Khosravi; Elham Khosravi
Journal:  ARYA Atheroscler       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.